Safety/Efficacy of Sitagliptin in Patient w/ Type 2 Diabetes (0431-801)

NCT00541775 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

273

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Sitagliptin
DRUG: Comparator: Rosiglitazone
DRUG: Comparator: Placebo
DRUG: Comparator: Metformin

Sponsor

Merck Sharp & Dohme LLC